RGS2

regulator of G protein signaling 2, the group of Regulators of G-protein signaling|Receptor ligands

Basic information

Region (hg38): 1:192809039-192812275

Previous symbols: [ "G0S8" ]

Links

ENSG00000116741NCBI:5997OMIM:600861HGNC:9998Uniprot:P41220AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the RGS2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the RGS2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
7
clinvar
1
clinvar
8
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
0
non coding
1
clinvar
1
Total 0 1 7 1 1

Variants in RGS2

This is a list of pathogenic ClinVar variants found in the RGS2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-192809069-A-G RGS2-related disorder Benign (Jun 07, 2019)3043677
1-192809103-A-G not specified Uncertain significance (Jun 01, 2023)2554929
1-192809120-G-A not specified Uncertain significance (Feb 17, 2024)3153861
1-192809139-G-A not specified Uncertain significance (Jun 02, 2016)403375
1-192810203-C-A Likely benign (May 09, 2018)712093
1-192810258-C-T not specified Uncertain significance (Jan 29, 2024)3153858
1-192810412-C-A not specified Uncertain significance (Aug 16, 2022)2307192
1-192810432-G-T Likely pathogenic (Feb 22, 2016)372899
1-192811125-T-C not specified Uncertain significance (Apr 24, 2024)3314101
1-192811135-A-C not specified Uncertain significance (Oct 03, 2023)3153860
1-192811477-G-A not specified Uncertain significance (Jun 01, 2023)2554883

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
RGS2protein_codingprotein_codingENST00000235382 53235
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.000005700.4561257110371257480.000147
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.01031051051.000.000005131409
Missense in Polyphen3338.930.84767576
Synonymous-1.024436.21.220.00000184357
Loss of Function0.570911.00.8154.78e-7146

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0003220.000322
Ashkenazi Jewish0.00009920.0000992
East Asian0.0002720.000272
Finnish0.00004620.0000462
European (Non-Finnish)0.0001500.000149
Middle Eastern0.0002720.000272
South Asian0.00009800.0000980
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Regulates G protein-coupled receptor signaling cascades. Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits, thereby driving them into their inactive GDP-bound form (PubMed:11063746, PubMed:19478087). It is involved in the negative regulation of the angiotensin-activated signaling pathway (PubMed:28784619). Plays a role in the regulation of blood pressure in response to signaling via G protein-coupled receptors and GNAQ. Plays a role in regulating the constriction and relaxation of vascular smooth muscle (By similarity). Binds EIF2B5 and blocks its activity, thereby inhibiting the translation of mRNA into protein (PubMed:19736320). {ECO:0000250|UniProtKB:O08849, ECO:0000269|PubMed:11063746, ECO:0000269|PubMed:11278586, ECO:0000269|PubMed:17901199, ECO:0000269|PubMed:19736320, ECO:0000269|PubMed:28784619, ECO:0000305|PubMed:7643615}.;
Pathway
Oxytocin signaling pathway - Homo sapiens (human);cGMP-PKG signaling pathway - Homo sapiens (human);Olfactory transduction - Homo sapiens (human);Glucocorticoid Receptor Pathway;Nuclear Receptors Meta-Pathway;Myometrial Relaxation and Contraction Pathways;Calcium Regulation in the Cardiac Cell;Signaling by GPCR;Signal Transduction;GPCR signaling-G alpha q;GPCR signaling-cholera toxin;GPCR signaling-pertussis toxin;GPCR signaling-G alpha s Epac and ERK;GPCR signaling-G alpha s PKA and ERK;GPCR signaling-G alpha i;G alpha (q) signalling events;GPCR downstream signalling (Consensus)

Recessive Scores

pRec
0.268

Intolerance Scores

loftool
0.610
rvis_EVS
-0.16
rvis_percentile_EVS
41.64

Haploinsufficiency Scores

pHI
0.203
hipred
Y
hipred_score
0.632
ghis
0.528

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.838

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Rgs2
Phenotype
renal/urinary system phenotype; immune system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); normal phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); muscle phenotype;

Zebrafish Information Network

Gene name
rgs2
Affected structure
migratory neural crest
Phenotype tag
abnormal
Phenotype quality
increased occurrence

Gene ontology

Biological process
response to amphetamine;cell cycle;spermatogenesis;brain development;regulation of G protein-coupled receptor signaling pathway;negative regulation of phospholipase activity;negative regulation of cardiac muscle hypertrophy;positive regulation of neuron projection development;negative regulation of translation;ovulation;negative regulation of MAP kinase activity;positive regulation of GTPase activity;negative regulation of cAMP-mediated signaling;response to ethanol;negative regulation of G protein-coupled receptor signaling pathway;brown fat cell differentiation;relaxation of cardiac muscle;relaxation of vascular smooth muscle;maternal process involved in female pregnancy;positive regulation of cardiac muscle contraction;negative regulation of cell growth involved in cardiac muscle cell development;negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process;negative regulation of glycine import across plasma membrane
Cellular component
nucleus;nucleolus;cytoplasm;mitochondrion;cytosol;plasma membrane;cytoplasmic side of plasma membrane;neuron projection
Molecular function
G-protein alpha-subunit binding;GTPase activator activity;protein binding;calmodulin binding;beta-tubulin binding